Page 233 - Read Online

Yap et al. Mini-invasive Surg 2019;3:3 I http://dx.doi.org/10.20517/2574-1225.2018.57 Page 9 of 9

institution. Tech Coloproctol 2014;18:473-80.
26. Penna M, Hompes R, Arnold S, Wynn G, Austin R, et al. Transanal total mesorectal excision: international registry results of the first
720 cases. Ann Surg 2017;266:111-7.
27. Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, et al. Transanal total mesorectal excision (TaTME) for rectal
cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017;21:25-33.
28. Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, et al. Potential sexual function improvement by using transanal mesorectal
approach for laparoscopic low rectal cancer excision. Surg Endosc 2016;30:4924-33.
29. Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, et al. COLOR III: a multicentre randomised clinical trial comparing
transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016;30:3210-5.
30. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, et al. Effect of laparoscopic-assisted resection vs open resection on
pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314:1356-63.
31. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or
III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
32. Kuo LJ, Ngu JC, Tong YS, Chen CC. Combined robotic transanal total mesorectal excision (R-taTME) and single-site plus one-port
(R-SSPO) technique for ultra-low rectal surgery-initial experience with a new operation approach. Int J Colorectal Dis 2017;32:249-54.